Abstract
Background Esophageal pressure (Pes) is used to approximate pleural pressure (PPL) and therefore to estimate transpulmonary pressure (PL).
Objectives We aimed to compare esophageal and regional pleural pressures and to calculate transpulmonary pressures in a prospective physiological study on lung transplant recipients during their stay in the intensive care unit of a tertiary university hospital.
Methods Lung transplant recipients receiving invasive mechanical ventilation and monitored by esophageal manometry and dependent and non-dependent pleural catheters were investigated during the post-operative period. We performed simultaneous short time measurements and recordings of esophageal manometry and pleural pressures. Expiratory and inspiratory PL were computed by subtracting regional PPL or Pes from airway pressure; inspiratory PL was also calculated with the elastance ratio method.
Results Sixteen patients were included. Among them, 14 were analyzed. Esophageal pressures correlated with dependent and non-dependent pleural pressures during expiration, respectively R2=0.71, p=0.005 and R2=0.77, p=0.001 and during inspiration, respectively, R2=0.66 for both (respectively p=0.01 and p=0.014). PL calculated using Pes were close to those obtained from the dependent pleural catheter but higher than those obtained from the non-dependent pleural catheter both during expiration and inspiration.
Conclusion In ventilated lung transplant recipients, esophageal manometry is well correlated to pleural pressure. Absolute value of Pes is higher than pleural pressure of non-dependent lung regions and could therefore underestimate the highest level of lung stress in these at high risk of overinflation.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Tilmont has nothing to disclose.
Conflict of interest: Dr. Coiffard has nothing to disclose.
Conflict of interest: Dr. Yoshida has nothing to disclose.
Conflict of interest: Dr. Daviet has nothing to disclose.
Conflict of interest: Dr. Baumstarck has nothing to disclose.
Conflict of interest: Dr. Brioude has nothing to disclose.
Conflict of interest: Dr. HRAIECH has nothing to disclose.
Conflict of interest: Dr. FOREL has nothing to disclose.
Conflict of interest: Dr. Roch has nothing to disclose.
Conflict of interest: Dr. Brochard reports grants from Medtronic Covidien, grants and non-financial support from Fisher Paykel, non-financial support from Sentec, non-financial support from Philips, non-financial support from Air Liquide, other from General Electric, outside the submitted work;.
Conflict of interest: Dr. PAPAZIAN reports grants and personal fees from Air Liquide, personal fees from Faron, grants from SEDANA, personal fees from MSD, outside the submitted work;.
Conflict of interest: Dr. GUERVILLY reports personal fees from Xenios Fresenus Medical Care, personal fees from MSD, outside the submitted work;.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received September 4, 2020.
- Accepted December 1, 2020.
- Copyright ©ERS 2021
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.